1093 · CSPC Pharmaceutical Group Limited

9.09

HKD

-0.20 (-2.154%)

09/10/2026 12:00:00 AM

Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

HK$106.99B

22.90

EV/EBITDA

15.2

DIV Yield

3.4%

Payout Ratio

79%

MQV Rating

1Very Strong

As at 09/10/2026 12:00:00 AM

Price Chart

Description

CSPC Pharmaceutical Group Ltd. is an investment holding company, which is engaged in the manufacturing and selling of pharmaceutical products. It operates through the following business segments: Finished Drugs, Bulk Products, and Functional Food and Others. The Finished Drugs segment manages research and development, manufacture and sale of pharmaceutical products and license fee income. The Bulk Products offers manufacturing and sale of vitamin C, and antibiotic products in bulk powder form. The Functional Food and Others segment refers to manufacturing and sale of functional food products, provision of healthcare services, and others. The company was founded on August 21, 1997 and is headquartered in Shijiazhuang, China.

All-Companies
All-Consensus
Consensus Cheap
EMA 125 Breakup
HALO 100
HALO 200
HALO 50
HALO All
HALO Capital Efficiency
HALO Earnings Momentum
HALO GARP
HALO Growth
HALO Momentum
HALO MQV
Recent Price upgrade

Key Fundamentals

EPS 3 yr Growth

-33.50%

EBITDA Margin

20.70%

Operating Cashflow

¥6,054m

Free Cash Flow Return

18.40%

ROIC

11.80%

Interest Coverage

139.50

Quick Ratio

1.90

Performance

52 weeks range

Low 6.53 - 10.96

Trade Value (12mth)

US$28,787,982.00

1 week

-7.8%

1 month

2.03%

YTD

9.49%

1 year

-0.91%

All time high

13.93

Additional Data

Shares Outstanding (Fully Diluted)

11,420m

HALO Sector

Healthcare

Next Company Report Date

24-Mar-27

Next Ex Dividend Date

20-Oct-26

Next Dividend Pay Date

10-Nov-26

Reporting Currency

CNY

Short Sell (% of issue)

0.00

Consensus

Unlock full consensus

Consensus score

/10

Recommendation

Buy

Target price

Deviation

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Strong

Garp

Very Strong

Mqv Small

Neutral

Momentum

Price

Strong

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Weak

Quality

Capital Efficiency

Very Strong

Balance Sheet

Neutral

Valuation

Unlock full dataset

Value

Consensus

Yield

News & Announcements

No announcements available.

Key Stakeholders

Name	Title
Dong Chen Cai	Individual
Common Success International Ltd.	Private Company
Massive Top Ltd.	Private Company
Invesco Great Wall Fund Management Co. Ltd.	Joint Venture
Orient Securities Co., Ltd.	Public Company